References
1. Sullivan M, Bouffet E, Rodriguez-Galindo C, Luna-Fineman S, Khan MS, Kearns P, et al. The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global. Pediatr Blood Cancer. 2020;67: e28409.
2. Montoya J, Ugaz C, Alarcon S, Maradiegue E, García J, Díaz R, et al. COVID‐19 in pediatric cancer patients in a resource‐limited setting: National data from Peru. Pediatric Blood & Cancer. 2021. doi:10.1002/pbc.28610
3. López-Aguilar E, Cárdenas-Navarrete R, Simental-Toba A, Pacheco-Rosas D, Thomé-Ortiz P, Soto-Pérez G, et al. Children with cancer during COVID-19 pandemic: Early experience in Mexico. Pediatric blood & cancer. 2021. p. e28660.
4. Graetz D, Agulnik A, Ranadive R, Vedaraju Y, Chen Y, Chantada G, et al. Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study. Lancet Child Adolesc Health. 2021;5: 332–340.
5. Millen GC, Arnold R, Cazier J-B, Curley H, Feltbower RG, Gamble A, et al. Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project. Br J Cancer. 2021;124: 754–759.
6. Connelly JA, Chong H, Esbenshade AJ, Frame D, Failing C, Secord E, et al. Impact of COVID-19 on Pediatric Immunocompromised Patients. Pediatr Clin North Am. 2021;68: 1029–1054.
7. Madhusoodhan PP, Pallavi Madhusoodhan P, Pierro J, Musante J, Kothari P, Gampel B, et al. Characterization of COVID‐19 disease in pediatric oncology patients: The New York‐New Jersey regional experience. Pediatric Blood & Cancer. 2021. doi:10.1002/pbc.28843
8. Kebudi R, Kurucu N, Tuğcu D, Hacısalihoğlu Ş, Fışgın T, Ocak S, et al. COVID‐19 infection in children with cancer and stem cell transplant recipients in Turkey: A nationwide study. Pediatric Blood & Cancer. 2021. doi:10.1002/pbc.28915
9. Mukkada S, Bhakta N, Chantada GL, Chen Y, Vedaraju Y, Faughnan L, et al. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol. 2021;22: 1416–1426.
10. de Rojas T, Pérez-Martínez A, Cela E, Baragaño M, Galán V, Mata C, et al. COVID-19 infection in children and adolescents with cancer in Madrid. Pediatr Blood Cancer. 2020;67: e28397.
11. Nicastro E, Verdoni L, Bettini LR, Zuin G, Balduzzi A, Montini G, et al. COVID-19 in Immunosuppressed Children. Frontiers in Pediatrics. 2021. doi:10.3389/fped.2021.629240
12. Zachariah P, Johnson CL, Halabi KC, Ahn D, Sen AI, Fischer A, et al. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children’s Hospital in New York City, New York. JAMA Pediatr. 2020;174: e202430.
13. Flores V, Miranda R, Merino L, González C, Serrano C, Solano M, et al. SARS-CoV-2 infection in children with febrile neutropenia. Ann Hematol. 2020;99: 1941–1942.
14. Corso MCM, Soares VJ, Amorim AMP, Cipolotti R, Magalhães IMQ, Lins MM, et al. SARS-CoV-2 in children with cancer in Brazil: Results of a multicenter national registry. Pediatr Blood Cancer. 2021;68: e29223.
15. Dorantes-Acosta E, Ávila-Montiel D, Klünder-Klünder M, Juárez-Villegas L, Márquez-González H. Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis. Front Oncol. 2020;10: 608282.
16. Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, Fattizzo B, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136: 2881–2892.
17. Bisogno G, Provenzi M, Zama D, Tondo A, Meazza C, Colombini A, et al. Clinical Characteristics and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Italian Pediatric Oncology Patients: A Study From the Infectious Diseases Working Group of the Associazione Italiana di Oncologia e Ematologia Pediatrica. Journal of the Pediatric Infectious Diseases Society. 2020. pp. 530–534. doi:10.1093/jpids/piaa088
18. Rouger-Gaudichon J, Bertrand Y, Boissel N, Brethon B, Ducassou S, Gandemer V, et al. COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE). Bulletin du Cancer. 2021. pp. 490–500. doi:10.1016/j.bulcan.2021.02.004
19. Baruchel A, Bertrand Y, Boissel N, Brethon B, Ducassou S, Gandemer V, et al. COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE). Bull Cancer. 2020;107: 629–632.
20. Fonseca EV, Pardo CA, Linares A, López JF, Camacho G, Aponte NH, et al. Clinical Characteristics and Outcomes of a Cohort of Pediatric Oncohematologic Patients With COVID-19 Infection in the City of Bogotá, Colombia. Pediatr Infect Dis J. 2021;40: 499–502.
21. Ferrari A, Zecca M, Rizzari C, Porta F, Provenzi M, Marinoni M, et al. Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy. Pediatric blood & cancer. 2020. p. e28410.
22. Instituto Nacional de Estadística y Censos (Argentina). Estimaciones y proyecciones de población 2010-2040: total del país. 2014.
23. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020. p. e20200702. doi:10.1542/peds.2020-0702
24. Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020;20: 689–696.
25. Fang F, Chen Y, Zhao D, Liu T, Huang Y, Qiu L, et al. Recommendations for the Diagnosis, Prevention, and Control of Coronavirus Disease-19 in Children-The Chinese Perspectives. Front Pediatr. 2020;8: 553394.
26. Boletín Integrado de Vigilancia. Edición Semanal. BIV 591 | SE 9/2022. Ministerio de Salud de la Nación; SE 9 Año 2022.
27. Hrusak O, Kalina T, Wolf J, Balduzzi A, Provenzi M, Rizzari C, et al. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. Eur J Cancer. 2020;132: 11–16.
28. Meena JP, Kumar Gupta A, Tanwar P, Ram Jat K, Mohan Pandey R, Seth R. Clinical presentations and outcomes of children with cancer and COVID-19: A systematic review. Pediatr Blood Cancer. 2021;68: e29005.
29. A multicenter study of confirmed COVID-19 cases: preliminary data on 2690 pediatric patients in Argentina during the first year of the pandemic. Archivos Argentinos de Pediatría. 2022. doi:10.5546/aap.2022.eng.80
30. Cribado de SARS-CoV-2 en pacientes pediátricos con cáncer previo a hospitalización para infusión de quimioterapia. Archivos Argentinos de Pediatría. 2022. doi:10.5546/aap.2022.118
31. Boulad F, Kamboj M, Bouvier N, Mauguen A, Kung AL. COVID-19 in Children With Cancer in New York City. JAMA Oncol. 2020;6: 1459–1460.
32. Moreira DC, Millen GC, Sands S, Kearns PR, Hawkins DS. The Care of Children With Cancer During the COVID-19 Pandemic. Am Soc Clin Oncol Educ Book. 2021;41: 1–10.
33. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology. 2020. pp. 335–337. doi:10.1016/s1470-2045(20)30096-6